Antibiotics in pregnancy: Analysis of potential risks and determinants in a large German statutory sickness fund population

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 5, 2006, Pages 327-337

  Amann, Ute ^a   Egen Lappe, Veronika ^a   Strunz Lehner, Christine ^a   Hasford, Joerg ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibiotics; Drug utilisation; Pregnancy; Prescription drugs; Risk classification; Teratogenicity

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEFIXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; MERCURY DERIVATIVE; METRONIDAZOLE; MINOCYCLINE; NEOMYCIN; NITROFURANTOIN; NITROXOLINE; OXYTETRACYCLINE; PENICILLIN DERIVATIVE; PENICILLIN V; PIPEMIDIC ACID; QUINOLINE DERIVATIVE; ROXITHROMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG USE; FEMALE; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; PRACTICE GUIDELINE; PREGNANCY DISORDER; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SOCIAL WELFARE; SOCIOECONOMICS; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DRUG UTILIZATION; FEMALE; FETUS; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK;

EID: 33744471114     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1225     Document Type: Article

References (38)

1. Collaborative group on drug use in pregnancy (CGDUP). Medication during pregnancy: An intercontinental cooperative study. Int J Gynecol Obstet 1992; 39: 185-196.
2. Heikkila AM. Antibiotics in pregnancy - a prospective cohort study on the policy of antibiotic prescription. Ann Med 1993 Oct; 25: 467-471.
3. Olesen C, Hald Steffensen F, Lauge Nielsen G, de Jong-van den Berg L, Olsen J, Toft Sorensen H, The Euromap group. Drug use in first pregnancy and lactation: A population-based survey among Danish women. Eur J Clin Pharmacol 1999; 55: 139-144.
4. Beyens MN, Guy C, Ratrema M, Ollagnier M. Prescription of drugs to pregnant women in France: The HIMAGE study. Therapie 2003; 58: 505-511.
5. Irl C, Hasford J, and the PEGASUS-Study Group. The PEGA-SUS-project - a prospective cohort study for the investigation of drug use in pregnancy. Int J Clin Pharmacol Ther 1997; 35: 572-576.
6. Bonati M, Bortolus R, Marchetti F, Romero M, Togoni G. Drug use in pregnancy: An overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 1990; 38: 325-328.
7. Headley J, Northstone K, Simmons H, Golding J, ALSPAC Study Team. Medication use during pregnancy: Data from the Avon Longitudinal Study of Parents and Children. Eur J Clin Pharmacol 2004; 60: 355-361.
8. http://www.dggg.de/leitlinien.html [cited September 22, 2004]
9. Millar LK, Cox SM. Urinary tract infections complicating pregnancy. Infect Dis Clin North Am 1997; 11: 13-26.
10. Nicolle LE. Screening for asymptomatic bacteriuria in pregnancy. In Canadian Guide to Clinical Preventive Health Care. Health Canada: Ottawa, 1994; 100-106 (http://www.ctfphc.org [cited September 22, 2004])
11. Rote Liste® 2004 - Arzneimittelverzeichnis für Deutschland. Rote Liste® Service GmbH, Frankfurt/Main, 2004.
12. Deutsche Homöopatische Union. Homöopatisches Repetitorium. Karlsruhe, 2004; 266-274
13. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Williams & Wilkins: Baltimore, 2002.
14. http://www.tga.gov.au/docs/html/mip/medicine.htmantimocrobials [cited September 22, 2004]
15. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998; 338: 1128-1137.
16. Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinato 2003; 20: 405-414.
17. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343: 1608-1614.
18. Einarson A, Shuhaiber S, Koren G. Effects of antibacterials on the unborn child: What is known and how should this influence prescribing. Paediatr Drugs 2001; 3: 803-816.
19. Grospietsch G. Erkrankungen in der Schwangerschaft: Ein Leitfaden mit Therapieempfehlungen für Klinik und Praxis. Wiss. Verl.-Ges.: Stuttgart, 2000; 107-110.
20. Working Party of the British Society for Antimicrobial Chemotherapy. Hospital antibiotic control measures in the UK. J Antimicrob Chemother 1994; 34: 21-42.
21. Hasford J. Pegasus. Bayerischer Forschungsverbund Public Health (BFV): München, 2002; p. 19.
22. De Vigan C, De Walle HEK, Cordier S, et al. Therapeutic drug use during pregnancy: A comparison in four European countries. J Clin Epidemiol 1999; 52: 977-982.
23. Egen-Lappe V, Hasford J. Drug prescription in pregnancy - analysis of a large statutory sickness fund population. Eur J Clin Epidemiol 2004; 60: 659-666.
24. Malm H, Martikainen J, Klaukka T, Neuvonen J. Prescription drugs during pregnancy and lactation - a Finnish register-based study. Eur J Clin Pharmacol 2003; 59: 127-133.
25. http://www.whocc.no/atcddd [cited September 22, 2004]
26. Zagorski BM, Trick WE, Schwartz DN, et al. The effect of renal dysfunction on antimicrobial use measurements. Clin Infect Dis 2002; 35: 1491-1497.
27. Natsch S, Hekster YA, de Jong R, Heerdink ER, Herings RM, van der Meer JW. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 1998; 17: 20-24.
28. De Jong-van den Berg LTW, van den Berg PB, Peters PWJ, Haaijer-Ruskamp FM. A study of drug utilization in pregnancy in the light of known risks: Is there room for improvement? Int J Risk Saf Med 1990; 1: 91-105.
29. Olesen C, Sorensen HT, de Jong-van den Berg L, Olsen J, Steffensen FH. Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. The Euromap Group. Acta Obstet Gynecol Scand 1999; 78: 686-692.
30. Piper JM, Baum C, Kennedy DL. Prescription drug use before and during pregnancy in a Medicaid population. Am J Obstet Gynecol 1987; 157: 148-156.
31. Buitendijk S, Bracken MB. Medication in early pregnancy: Prevalence of use and relationship to maternal characteristics. Am J Obstet Gynecol 1991; 165: 33-40.
32. Brocklebank JC, Ray WA, Federspiel CF, Schaffner W. Drug prescribing during pregnancy. A controlled study of Tennessee Medicaid recipients. Am J Obstet Gyneco 1978; 132: 235-244.
33. Strunz-Lehner C, Egen-Lappe V, Hasford J, Janhsen K, Glaeske G. The impact of region, age and social status on drug prescribing during pregnancy. Pharmacoepidemiol Drug Saf 2004; 13: S182.
34. Garcia I, Beyens MN, Gauchoux R, Guy C, Ollagnier M. Prescription médicamenteuse chez la femme enceinte dans le département de la Loire. Thérapie 2000; 55: 605-611.
35. Nordeng H, Eskild A, Nesheim BI, Aursnes I, Jacobsen G. Drug use during early pregnancy. The impact of maternal illness, outcome of prior pregnancies and socio-demographic factors. Eur J Clin Pharmacol 2001; 57: 259-263.
36. Thinkhamrop J, Hofmeyr GJ, Adetoro O, Lumbiganon P. Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality (Cochrane Review, 2002). In The Cochrane Library. John Wiley & Sons, Ltd: Chichester, UK, 2004, Issue 2.
37. Reimann I, Karpinsky C, Hoffmann A. Epidemiological data on drug use during pregnancy in Thuringia, East Germany, 1993. Int J Clin Pharmacol Ther 1996; 34: 80-83.
38. Olesen C, Sondergaard C, Thrane N, Nielsen GL, de Jong-van den Berg L, Olsen J, EuroMAP Group. Do pregnant women report use of dispensed medications? Epidemiology 2001; 12: 497-501.